Novel functional multiparameter flow cytometric assay to characterize proliferation in skin

Abstract

Keratins are a group of cytoskeletal proteins that are found in human epidermis and other stratified squamous epithelia. Several different types of keratins have been described. Keratin 10 (K10) is a keratin that is expressed in well differentiated, suprabasal keratinocytes, and keratin 6 (K6) is a keratin which is associated with hyperproliferation. Psoriasis is a chronic inflammatory skin disease, and besides inflammation, disturbed differentiation and hyperproliferation are its hallmarks. In order to study the hyperproliferation associated keratinization in both well differentiated and poorly differentiated keratinocytes, and in order to assess the proliferative activity of all K10 and K6 subpopulations, simultaneous assessment of K6, K10, and DNA content is required. So far, a triple staining protocol had not been available. In the present study, we established a novel protocol for simultaneous measurement of K6, K10, and DNA content, which enables the characterization of the proliferative activity of several cellular subpopulations in epidermis. From 16 patients with psoriasis and from 15 healthy volunteers, punch biopsies were obtained. After preparation of single cell suspensions, cells were stained with the anti‐keratin 10 IgG1‐isotype monoclonal antibody RKSE60, with the anti‐keratin 6 IgG2a‐isotype monoclonal antibody LHK6B, and with the DNA fluorochrome TO‐PRO‐3 iodide. Isotype specific secondary antibodies conjugated with phycoerythrein (PE) and fluorescein isothiocyanate (FITC) were used as the second step in the staining procedure. Controls were measured omitting the primary antibodies, and gates were set in order to differentiate between the K10 and K6 subpopulations. Samples from both psoriatic patients and healthy volunteers were than measured. Owing to the IgG specificity of RKSE60 and LHK6B, no cross‐reactivity was observed between these antibodies. The triple staining with RKSE60, LHK6B, and TO‐PRO‐3 iodide showed subpopulations of K10 expressing cells, K10/K6 co‐expressing cells, and K6 only expressing cells. There was a significant difference in the proportion of K6 expression and K10/K6 co‐expression between psoriatic and normal skin. Moreover, the proliferative activity of these subpopulations could be quantified by this protocol. We concluded that a triple staining protocol for the assessment of K6, K10, and DNA content, using the monoclonal antibodies LHK6B, RKSE60, and TO‐PRO‐3 iodide, supplies reliable and reproducible data for cellular studies on these keratins and for studying the proliferative activity of the subpopulations of these keratins in epidermis. Moreover, the present study showed that with respect to the proportion of K6, significant differences are present between psoriatic and healthy human skin.Cytometry (Comm. Clin. Cytometry) 1:43–49, 2000 © 2000 Wiley‐Liss, Inc.

Cardiomyogenesis in the Aging and Failing Human Heart

“…The latter is critical for the accessibility of the DNA by this technique. 20 These inherent problems are avoided by the use of flow-cytometry that has become the gold standard for measurement of nuclear ploidy in various organs, including liver, 21 brain, 22 intestine, 23 skin, 24 kidney, 25 and cancer cells. 26,27 …”

A multiparameter flow cytometric analysis of the effect of bexarotene on the epidermis of the psoriatic lesion

“…A countstop was set at 10 000 single cells. Using ModFit software (ModFit LT 2.0, Verity Software House), the proportion of cells in different phases of the cell cycle, gated for each subpopulation was calculated, as described previously 12 …”

Effect of calcipotriol on epidermal cell populations in alefacept‐treated psoriatic lesions

“…21,22 The altered differentiation in psoriasis is also shown by the replacement of keratin 10 by keratin 6. [23][24][25][26][27][28] Major differences in expression of the above-mentioned epidermal cell markers between normal and psoriatic epidermis were shown with fluorescent immunohistochemistry using the Zenon technique, which can detect even small changes in epidermal cell populations after mild treatment of psoriasis. 29…”